Dermata Therapeutics, Inc. |
President, CEO and Chairman, Director, 10%+ Owner |
Common Stock |
800K |
|
|
Jan 21, 2025 |
By Proehl Investment Ventures LLC |
Dermata Therapeutics, Inc. |
President, CEO and Chairman, Director, 10%+ Owner |
Warrant (Right to Buy) |
787K |
|
|
Jan 21, 2025 |
By Proehl Investment Ventures LLC |
TENAX THERAPEUTICS, INC. |
Director |
Stock Option (right to buy) |
100K |
|
|
Dec 10, 2024 |
Direct |
Dermata Therapeutics, Inc. |
President, CEO and Chairman, Director, 10%+ Owner |
Stock Option (right to buy) |
45K |
|
|
Jan 13, 2025 |
Direct |
TENAX THERAPEUTICS, INC. |
Director |
Pre-Funded Warrant |
31.7K |
|
|
Dec 10, 2024 |
Direct |
TENAX THERAPEUTICS, INC. |
Director |
Warrant |
16.7K |
|
|
Dec 10, 2024 |
Direct |
TENAX THERAPEUTICS, INC. |
Director |
Common Stock |
1.67K |
|
|
Dec 10, 2024 |
Direct |
Dermata Therapeutics, Inc. |
President, CEO and Chairman, Director, 10%+ Owner |
Common Stock |
595 |
|
|
Jan 21, 2025 |
By Proehl Family Trust |
Dermata Therapeutics, Inc. |
President, CEO and Chairman, Director, 10%+ Owner |
Common Stock |
247 |
|
|
Jan 21, 2025 |
Direct |
Dermata Therapeutics, Inc. |
President, CEO and Chairman, Director, 10%+ Owner |
Common Stock |
149 |
|
|
Jan 21, 2025 |
By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020 |
Dermata Therapeutics, Inc. |
President, CEO and Chairman, Director, 10%+ Owner |
Common Stock |
74 |
|
|
Jan 21, 2025 |
By Allison Taylor Proehl 2020 Irrevocable Trust |
Dermata Therapeutics, Inc. |
President, CEO and Chairman, Director, 10%+ Owner |
Common Stock |
37 |
|
|
Jan 21, 2025 |
By Meghan Proehl Wilder 2020 Irrevocable Trust |